The DOI matches its Crossref record.
VALVE DISEASE: Prosthetic valve endocarditis
Open accessAbstract
After 40 years of continuous improvements in the design and materials used for prosthetic heart valves, valve replacement surgery is now performed with low morbidity and mortality. These advantages have been hampered by a few but severe adverse effects; in particular, infections of the prosthetic material continue to be an extremely serious complication occurring with a relatively low but increasing frequency ranging from 0.1–2.3% per patient year.1-3 The prosthesis obviously predisposes to device related infections, especially those caused by novobiocin susceptible, coagulase negative staphylococci, which are able to adhere to a variety of surfaces4 and produce an antibiotic resistant biofilm.5 6 Prosthetic valve endocarditis (PVE) is an endovascular, microbial infection occurring on parts of a valve prosthesis or on reconstructed native heart valves.7 It is recommended to determine whether (a) a mechanical prosthesis, (b) a bioprosthetic xenograft, stented or unstented, (c) an allograft, (d) a homograft, or (e) a repaired native valve with or without implantation of an annular ring is involved.8 Although clinical relevance and therapeutic considerations may be similar, infections of devices or lines placed inside the heart but not connected to the endocardial structures should be classified as “polymer associated infections” rather than PVE. PVE should be classified as either being acquired perioperatively, and thus nosocomial (early PVE), or as community acquired (late PVE).8 Because of significant differences in microbiology of PVE observed within the first year of operation and later on, the time cut off point between early and late PVE should be regarded as one year.9 The risk for early PVE is higher (approximately 5%) in patients with replacement surgery during active infective endocarditis, especially if the causal organism is unknown or the antibiotic treatment is insufficient. The incidence of late PVE is lower for mechanical prostheses than …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
Metadata
- Authors
- Piper, C.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2001-05-01
- Volume
- 85
- Issue
- 5
- Pages
- 590-593
- ISSN
- 0007-0769 (ISSN-L)
- OpenAlex
- W2154313489
- Cited by
- 183
- References
- 0
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: VALVE DISEASE: Prosthetic valve endocarditis. https://app.cochat.ai/papers/10.1136/heart.85.5.590
- The paper
- Piper, C. (2001). VALVE DISEASE: Prosthetic valve endocarditis. Heart. https://doi.org/10.1136/heart.85.5.590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.